Parameter | Number (%) |
---|---|
Gender (male) | 76 (64.4%) |
Age (mean±SD) | 63.6±17.5 years |
Smoking | 31 (26.3%) |
Alcohol drinking | 18 (15.3%) |
Concomitant disease | |
 Chronic lung diseases | 7 (5.9%) |
 Cerebrovascular diseases | 7 (5.9%) |
 Cardiovascular diseases | 53 (44.9%) |
 Renal failure | 7 (5.9%) |
 Cancer diseases | 12 (10.2%) |
 Liver disease | 12 (10.2%) |
 Diabetes mellitus | 25 (21.2%) |
Juxtapapillary diverticulum | 45 (38.1%) |
Gallbladder stones | 86 (72.9%) |
Biliary pancreatitis | 24 (20.3%) |
CBD diameter (mean±SD) | 1.2±0.4 cm |
Number of CBD stones (no/single /multiple) | 23/59/36 (20/50/30) |
Largest CBD stones size (mean±SD)a | 0.9±0.4 cm |
Endoscopic procedures (EST/EPBD) | 5/113 (4/96) |
Mean balloon diameter for EPBD (mean±SD) | 1.1±0.2 cm |
Mechanical lithotripsy | 12 (10.2%) |
Sessions for bile duct clearance(> 1 session) | 8 (6.8%) |
Stone colora | |
 Cholesterol and black pigment stones | 44 (46%) |
 Brown pigment stones | 51 (54%) |
Mean ERCP procedure time (mean±SD) | 49.2±22.2 min |
Postprocedural complications | 4 (3.4%) |
Follow up time (median, range) months | 33 (15 to 56) |
Recurrent biliary complications | 23 (19.5%) |
Spontaneous passage of gallstones | 15 (15/86 = 17.4%) |
Death during follow up | 6 (5.1%) |